Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving Q2W chemotherapy regimen: A systematic review of efficacy, effectiveness, and safety (20190355) (Pegfilgrastim in Q2W regimen: A systematic review)

First published 16/11/2019

Last updated 07/12/2020

EU PAS number:

EUPAS31967

Study

Finalised

Documents

Study protocol

Initial protocol

01.02.06 Public Redacted Protocol Ver 1.0 2019-10-08 English

English (332.83 KB - PDF)View document

Study results

20190355_Observational Research Study Report Published Report_Redacted

English (354.02 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs